del Nido停搏液在成人心脏手术主动脉阻断时间延长中的疗效
该研究回顾性分析2014年5月至2019年9月在本中心接受主动脉阻断时间≥90分钟的2506例成人心脏手术患者,比较del Nido停搏液(DC)与血停搏液(BC)的心肌保护效果和临床结局。倾向性评分匹配后526对患者中,DC组与BC组在围术期死亡、卒中、肾衰竭、房颤、主动脉内球囊反搏和体外膜肺氧合使用上无显著差异,但DC组术后肌钙蛋白T较低;亚组分析显示阻断时间150-180分钟时DC组肌钙蛋白T较高。结论认为在主动脉阻断时间>90分钟的成人心脏手术中,DC与BC相比具有相当的心肌保护、围术期死亡率和发病率及远期生存率。
要点
- 倾向性评分匹配后,DC组与BC组围术期死亡、卒中、肾衰竭、房颤、IABP和ECMO使用均无显著差异。
- DC组术后肌钙蛋白T中位数0.53 ng/mL,BC组0.62 ng/mL,DC组较低(P=0.0024)。
- 主动脉阻断时间150-180分钟亚组中DC组肌钙蛋白T较高,但未增加死亡率。
核心结论
- 在主动脉阻断时间>90分钟的成人心脏手术中,DC与BC相比观察到相当的心肌保护、围术期死亡率和发病率及远期生存率。
- 主动脉阻断时间150-180分钟的患者中DC组肌钙蛋白水平较高,但未与死亡率增加相关。
研究设计与样本
- 回顾性研究,纳入2014年5月至2019年9月在本中心接受主动脉阻断时间≥90分钟的2506例成人心脏手术患者。
- BC组1955例,DC组551例;研究期间2名外科医生完全使用DC,5名完全使用BC。
- BC采用顺行和逆行灌注,DC仅采用顺行灌注。
- 倾向性评分匹配包括主要心脏病理在内的多项术前特征,得到526对匹配良好的患者。
- 纳入急诊和再次手术病例;术后12小时检测所有患者的肌钙蛋白T水平;临床数据提取自本中心胸外科医师学会数据库。
主要发现
- 倾向性评分匹配队列中,DC组主动脉阻断时间中位数114分钟(IQR 100-145),BC组153分钟(IQR 122-200),DC组较短(P<.0001)。
- 术中血糖峰值DC组173 g/dL(IQR 147-200),BC组197 g/dL(IQR 171-228),DC组较低(P<.001)。
- 围术期死亡率DC组3.4% vs BC组3.0%(P=.7273),卒中DC组3.2% vs BC组2.1%(P=.2504),肾衰竭DC组6.5% vs BC组4.6%(P=.1767),房颤DC组34% vs BC组31.4%(P=.3575),IABP使用DC组5.3% vs BC组4.6%(P=.5694),ECMO使用DC组3.0% vs BC组2.9%(P=.8596),均无显著差异。
- 术后肌钙蛋白T中位数DC组0.53 ng/mL(IQR 0.30-0.96),BC组0.62 ng/mL(IQR 0.38-1.07),DC组较低(P=.0024)。
- 亚组分析显示主动脉阻断时间150-180分钟时DC组肌钙蛋白T水平较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Equivalent myocardial protection and clinical outcomes have been shown with the use of del Nido cardioplegia (DC) compared with blood cardioplegia (BC) in adult isolated coronary artery bypass grafting and valve patients. However, its safety and efficacy in cardiac procedures with aortic crossclamp times >90 minutes is still unknown. METHODS: From May 2014 to September 2019, 2506 adult patients at our center underwent cardiac surgery requiring prolonged aortic crossclamp time defined as 90 minutes or longer. Myocardial protection was achieved with BC in 1955 patients and DC in 551 patients. Two surgeons used DC exclusively and 5 used blood exclusively over the study period. BC was delivered anterograde and retrograde whereas DC was delivered anterograde only. Propensity score matching of several preoperative characteristics, including primary cardiac pathology, yielded 526 well matched pairs. Emergency and reoperative cases were included. Troponin T levels were drawn at 12 hours postoperative in all patients. Clinical data were extracted from our local Society of Thoracic Surgeons database. Subgroup analyses were performed on the basis of crossclamp time stratification. RESULTS: For the propensity score-matched cohort, the median crossclamp time was longer in the BC compared with the DC group (114 [interquartile range (IQR), 100-145] minutes for DC vs 153 [IQR, 122-200] minutes for BC; P < .0001) whereas intraoperative peak glucose was higher with BC (173 [IQR, 147-200] g/dL for DC vs 197 [IQR, 171-228] g/dL for BC; P < .001). In addition, perioperative mortality (3.4% vs 3.0%; P = .7273), stroke (3.2% vs 2.1%; P = .2504), renal failure (6.5% vs 4.6%; P = .1767), atrial fibrillation (34% vs 31.4%, P = .3575), intra-aortic balloon pump use (5.3% vs 4.6%, P = .5694), and extracorporeal membrane oxygenation use (3.0% vs 2.9%, P = .8596) did not differ between DC and BC. Postoperative troponin T levels were 0.53 (IQR, 0.30-0.96) ng/mL and 0.62 (IQR, 0.38-1.07) ng/mL for DC and BC, respectively (P = .0024). Subgroup analysis revealed higher troponin T levels with DC for crossclamp times between 150 and 180 minutes. Survival rates at 1, 2, and 5 years were 93.3%, 91.1%, and 78.7% for DC and 94.5%, 91.8%, and 81.5% for BC, respectively (P = .5140). CONCLUSIONS: In adult cardiac surgical procedures with aortic crossclamp times >90 minutes, comparable myocardial protection, perioperative mortality and morbidity, and distant survival were observed with the use of DC compared with BC. Higher troponin levels were seen in DC patients with crossclamp times between 150 and 180 minutes, but this was not associated with increased mortality.
引用
- Willekes H, Parker J, Neill J, et al. Efficacy of del Nido cardioplegia in adult cardiac procedures with prolonged aortic crossclamp time. J Thorac Cardiovasc Surg. 2022. PMID: 35660325. doi:10.1016/j.jtcvs.2022.02.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。